Metabolic Health

Metabolic Health & Insulin Sensitivity Stack

Metabolic syndrome is driven by visceral fat accumulation, mitochondrial dysfunction, and gut-derived inflammation — not a single deficiency — and this stack addresses all three roots. Tesamorelin is the most clinically validated compound for visceral fat reduction, consistently reducing abdominal adipose tissue by 10–15% in trials while improving lipid profiles; MOTS-c addresses the mitochondrial dysfunction that both causes and perpetuates insulin resistance at the cellular level; and BPC-157 heals the intestinal permeability that drives the hepatic inflammatory signaling central to metabolic syndrome. Fasted morning timing for Tesamorelin is essential — insulin suppresses GH release and negates its lipolytic effects.

Intermediate 14 week cycle 3 peptides Save
For educational and research purposes only. Not medical advice. This protocol describes research use, not human administration. Always consult a qualified professional.

Protocol & Dosing

Morning Fasted Protocol:

  • Tesamorelin: 1 mg subcutaneously each morning (fasted, 30 min before eating)
  • MOTS-c: 5–10 mg subcutaneously 3–5x per week
Daily Gut-Axis Support:
  • BPC-157: 500 mcg orally (dissolved in water, empty stomach) twice daily
Cycle: 14 weeks on / 6 weeks off

Notes: Fasted morning timing is essential for Tesamorelin — insulin suppresses GH release and negates its lipolytic effects. Pair with a whole-food, low-glycemic diet and minimum 150 minutes per week of combined aerobic and resistance exercise. Fasting glucose and insulin (to calculate HOMA-IR) at baseline and post-cycle provides objective outcome tracking. This stack is not a substitute for dietary discipline — it amplifies the results of a metabolic-supportive lifestyle.

Calculate Doses for This Stack

Use the Peptide Oracle calculator to get exact BAC water ratios and draw amounts for every peptide in this protocol.

Open Dosage Calculator